Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Matti Davis is active.

Publication


Featured researches published by Matti Davis.


Nature | 1998

Identification of the receptor component of the IκBα-ubiquitin ligase

Avraham Yaron; Ada Hatzubai; Matti Davis; Iris Lavon; Sharon Amit; Anthony M. Manning; Jens S. Andersen; Matthias Mann; Frank Mercurio; Yinon Ben-Neriah

NF-κB, a ubiquitous, inducible transcription factor involved in immune, inflammatory, stress and developmental processes, is retained in a latent form in the cytoplasm of non-stimulated cells by inhibitory molecules, IκBs. Its activation is a paradigm for a signal-transduction cascade that integrates an inducible kinase and the ubiquitin–proteasome system to eliminate inhibitory regulators. Here we isolate the pIκBα–ubiquitin ligase (pIκBα-E3) that attaches ubiquitin, a small protein which marks other proteins for degradation by the proteasome system, to the phosphorylated NF-κB inhibitor pIκBα. Taking advantage of its high affinity to pIκBα, we isolate this ligase from HeLa cells by single-step immunoaffinity purification. Using nanoelectrospray mass spectrometry, we identify the specific component of the ligase that recognizes the pIκBα degradation motif as an F-box/WD-domainprotein belonging to a recently distinguished family of β-TrCP/Slimb proteins. This component, which we denote E3RSIκB (pIκBα-E3 receptor subunit), binds specifically to pIκBα and promotes its in vitro ubiquitination in the presence of two other ubiquitin-system enzymes, E1 and UBC5C, one of many known E2 enzymes. An F-box-deletion mutant of E3RSIκB, which tightly binds pIκBα but does not support its ubiquitination, acts in vivo as a dominant-negative molecule, inhibiting the degradation of pIκBα and consequently NF-κB activation. E3RSIκB represents a family of receptor proteins that are core components of a class of ubiquitin ligases. When these receptor components recognize their specific ligand, which is a conserved, phosphorylation-based sequence motif, they target regulatory proteins containing this motif for proteasomal degradation.


Nature | 1998

Identification of the receptor component of the IkappaBalpha-ubiquitin ligase.

Avraham Yaron; Ada Hatzubai; Matti Davis; Iris Lavon; Sharon Amit; Anthony M. Manning; Jens S. Andersen; Matthias Mann; Frank Mercurio; Yinon Ben-Neriah

NF-κB, a ubiquitous, inducible transcription factor involved in immune, inflammatory, stress and developmental processes, is retained in a latent form in the cytoplasm of non-stimulated cells by inhibitory molecules, IκBs. Its activation is a paradigm for a signal-transduction cascade that integrates an inducible kinase and the ubiquitin–proteasome system to eliminate inhibitory regulators. Here we isolate the pIκBα–ubiquitin ligase (pIκBα-E3) that attaches ubiquitin, a small protein which marks other proteins for degradation by the proteasome system, to the phosphorylated NF-κB inhibitor pIκBα. Taking advantage of its high affinity to pIκBα, we isolate this ligase from HeLa cells by single-step immunoaffinity purification. Using nanoelectrospray mass spectrometry, we identify the specific component of the ligase that recognizes the pIκBα degradation motif as an F-box/WD-domainprotein belonging to a recently distinguished family of β-TrCP/Slimb proteins. This component, which we denote E3RSIκB (pIκBα-E3 receptor subunit), binds specifically to pIκBα and promotes its in vitro ubiquitination in the presence of two other ubiquitin-system enzymes, E1 and UBC5C, one of many known E2 enzymes. An F-box-deletion mutant of E3RSIκB, which tightly binds pIκBα but does not support its ubiquitination, acts in vivo as a dominant-negative molecule, inhibiting the degradation of pIκBα and consequently NF-κB activation. E3RSIκB represents a family of receptor proteins that are core components of a class of ubiquitin ligases. When these receptor components recognize their specific ligand, which is a conserved, phosphorylation-based sequence motif, they target regulatory proteins containing this motif for proteasomal degradation.


Genes & Development | 2010

Spermatogenesis rescue in a mouse deficient for the ubiquitin ligase SCFβ-TrCP by single substrate depletion

Naama Kanarek; Elad Horwitz; Inbal Mayan; Michael Leshets; Gady Cojocaru; Matti Davis; Ben-Zion Tsuberi; Eli Pikarsky; Michele Pagano; Yinon Ben-Neriah

beta-TrCP, the substrate recognition subunit of a Skp1-Cul1-F-box (SCF) ubiquitin ligase, is ubiquitously expressed from two distinct paralogs, targeting many regulatory proteins for proteasomal degradation. We generated inducible beta-TrCP hypomorphic mice and found that they are surprisingly healthy, yet have a severe testicular defect. We show that the two beta-TrCP paralogs have a nonredundant role in spermatogenesis. The testicular defect is tightly associated with cell adhesion failure within the seminiferous tubules and is fully reversible upon beta-TrCP restoration. Remarkably, testicular depletion of a single beta-TrCP substrate, Snail1, rescued the adhesion defect and restored spermatogenesis. Our studies highlight an unexpected functional reserve of this central E3, as well as a bottleneck in a specific tissue: a single substrate whose stabilization is incompatible with testicular differentiation.


Nature Immunology | 2004

Behind the scenes of anergy: a tale of three E3s

Matti Davis; Yinon Ben-Neriah

Anergy induction initiates a transcription program involving the upregulation of several ubiquitin ligases (E3s). New data show how these E3s contribute to the establishment of anergy.


Nature | 1998

Identification of the receptor component of the I|[kappa]|B|[alpha]||[ndash]|ubiquitin ligase

Avraham Yaron; Ada Hatzubai; Matti Davis; Iris Lavon; Sharon Amit; Anthony M. Manning; Jens S. Andersen; Matthias Mann; Frank Mercurio; Yinon Ben-Neriah

NF-κB, a ubiquitous, inducible transcription factor involved in immune, inflammatory, stress and developmental processes, is retained in a latent form in the cytoplasm of non-stimulated cells by inhibitory molecules, IκBs. Its activation is a paradigm for a signal-transduction cascade that integrates an inducible kinase and the ubiquitin–proteasome system to eliminate inhibitory regulators. Here we isolate the pIκBα–ubiquitin ligase (pIκBα-E3) that attaches ubiquitin, a small protein which marks other proteins for degradation by the proteasome system, to the phosphorylated NF-κB inhibitor pIκBα. Taking advantage of its high affinity to pIκBα, we isolate this ligase from HeLa cells by single-step immunoaffinity purification. Using nanoelectrospray mass spectrometry, we identify the specific component of the ligase that recognizes the pIκBα degradation motif as an F-box/WD-domainprotein belonging to a recently distinguished family of β-TrCP/Slimb proteins. This component, which we denote E3RSIκB (pIκBα-E3 receptor subunit), binds specifically to pIκBα and promotes its in vitro ubiquitination in the presence of two other ubiquitin-system enzymes, E1 and UBC5C, one of many known E2 enzymes. An F-box-deletion mutant of E3RSIκB, which tightly binds pIκBα but does not support its ubiquitination, acts in vivo as a dominant-negative molecule, inhibiting the degradation of pIκBα and consequently NF-κB activation. E3RSIκB represents a family of receptor proteins that are core components of a class of ubiquitin ligases. When these receptor components recognize their specific ligand, which is a conserved, phosphorylation-based sequence motif, they target regulatory proteins containing this motif for proteasomal degradation.


Genes & Development | 2002

Pseudosubstrate regulation of the SCF(beta-TrCP) ubiquitin ligase by hnRNP-U

Matti Davis; Ada Hatzubai; Jens S. Andersen; Etti Ben-Shushan; Gregory Zvi Fisher; Avraham Yaron; Asne R. Bauskin; Frank Mercurio; Matthias Mann; Yinon Ben-Neriah


Archive | 2001

Methods for identifying inhibitors of ubiquitin-mediated proteolysis of ikb

Yinon Ben-Neriah; Irit Alkalay; Ada Hatzubai; Etti Ben-Shushan; Matti Davis; Avraham Yaron


Archive | 2002

Methods for identifying compounds that inhibit ubiquitin-mediated proteolysis of IkappaB

Yinon Ben-Neriah; Irit Alkalay-Snir; Ada Hatzubai; Etti Ben Shushan; Matti Davis; Avraham Yaron


Archive | 2001

Procede d'identification de composes inhibant la proteolyse a mediation assuree par l'ubiquitine de ikb

Yinon Ben-Neriah; Irit Alkalay; Ada Hatzubai; Etti Ben-Shushan; Matti Davis; Avraham Yaron


Archive | 1999

Human ubiquitin ligase E3. use for the modulation of NF-kappa B

Anthony M. Manning; Frank Mercurio; Sharon Amit; Yinon Ben-Neriah; Matti Davis; Ada Hatzubai; Iris Lavon; Avraham Yaron

Collaboration


Dive into the Matti Davis's collaboration.

Top Co-Authors

Avatar

Yinon Ben-Neriah

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Ada Hatzubai

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Avraham Yaron

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

Iris Lavon

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Sharon Amit

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

Jens S. Andersen

University of Southern Denmark

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Irit Alkalay

Hebrew University of Jerusalem

View shared research outputs
Researchain Logo
Decentralizing Knowledge